Product Information
LOHIST-DM SYRUP is a generic product labeled by Larken Laboratories, Inc., priced at $0.0741 per ML under NDC 68047012916. Its NADAC has been published 94 times since Mar 19, 2014.
LOHIST-DM SYRUP
Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine HydrochlorideStrength
2; 10; 5 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Larken Laboratories, Inc.NDC
68047012916
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/1/2012
Pharmacological Classes
Price Statistics
The NADAC for LOHIST-DM SYRUP has been published 94 times since Mar 19, 2014, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0741 per ML |
|---|---|
| All-time high | $0.0746 (Sep 16, 2026) |
| All-time low | $0.0666 (Apr 22, 2015) |
| 52-week high | $0.0746 |
| 52-week low | $0.0703 |
| Median price | $0.0703 |
| Average price | $0.0708 |
| Largest weekly change | +5.3% (Mar 19, 2025) |
| Weeks tracked | 94 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Larken Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOHIST-DM SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for LOHIST-DM SYRUP, manufactured by Larken Laboratories, Inc., is $0.0741 per ML (NDC 68047012916), effective Sep 30, 2026.
How has the price of LOHIST-DM SYRUP changed over time?
Over the history we have for it, the NADAC for LOHIST-DM SYRUP has risen 5.5%. It has been tracked across 94 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for LOHIST-DM SYRUP?
Since Mar 19, 2014, the NADAC for LOHIST-DM SYRUP has ranged from a low of $0.0666 (Apr 22, 2015) to a high of $0.0746 (Sep 16, 2026), with a median of $0.0703 per ML.
Are there cheaper alternatives to LOHIST-DM SYRUP?
No other NADAC-published product currently shares the active ingredient and strength of LOHIST-DM SYRUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LOHIST-DM SYRUP?
LOHIST-DM SYRUP (NDC 68047012916) is labeled by Larken Laboratories, Inc., and CMS classifies it as a generic product.